Keyphrases
Pharmacological Inhibitors
100%
Novel Therapeutics
100%
Adenosine Diphosphate Ribose
100%
Polymerase
100%
Polyadenosine
100%
Chronic Heart Failure
100%
Tyrosine
60%
Vascular Relaxation
60%
PJ34
40%
Left Ventricular Function
40%
Cardiac Dysfunction
40%
Aortic Rings
20%
Oxidative Stress
20%
Tissue Injury
20%
Myocardium
20%
Shock
20%
Immunohistochemistry
20%
Wistar Rats
20%
Rat Model
20%
Experimental Therapeutics
20%
Endothelial Dysfunction
20%
Left Anterior Descending Coronary Artery
20%
Diabetes
20%
Poly(adenosine diphosphate-ribose) Polymerase inhibitor
20%
Heart Transplantation
20%
Ligation
20%
Myocardial Ischemia-reperfusion Injury
20%
Poly (ADP-ribose) Polymerase Inhibition
20%
Vasculature
20%
Vascular Contraction
20%
Pathophysiologic
20%
Overactivation
20%
Cell Dysfunction
20%
Medicine and Dentistry
Poly ADP Ribose Polymerase
100%
Heart Failure
100%
3 Nitrotyrosine
42%
N (5,6 Dihydro 6 Oxo 2 Phenanthridinyl) 2 Dimethylaminoacetamide
28%
Myocardium
14%
Oxidative Stress
14%
Immunohistochemistry
14%
Tissue Injury
14%
Heart Left Ventricle Performance
14%
Shock (Circulatory)
14%
Diabetes
14%
Left Anterior Descending Coronary Artery
14%
Ex Vivo
14%
Heart Left Ventricle Function
14%
Muscle Contractility
14%
Apoplexy
14%
Experimental Therapy
14%
Endothelial Dysfunction
14%
Myocardial Ischemia Reperfusion Injury
14%
Vascularity
14%
Heart Transplantation
14%
Ligation
14%
Pharmacology, Toxicology and Pharmaceutical Science
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
100%
Heart Failure
100%
3 Nitrotyrosine
42%
N (5,6 Dihydro 6 Oxo 2 Phenanthridinyl) 2 Dimethylaminoacetamide
28%
Tissue Injury
14%
Wistar Rat
14%
Rat Model
14%
Endothelial Dysfunction
14%
Myocardial Ischemia Reperfusion Injury
14%